Nyaditum Resae ® as a Co-adjuvant During First-line Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota

Condition:   Tuberculosis Interventions:   Dietary Supplement: Nyaditum resae®;   Other: Mannitol Sponsors:   University of Stellenbosch;   Fundació Institut Germans Trias i Pujol Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

Source: Infection and Drug Resistance - Category: Infectious Diseases Tags: Infection and Drug Resistance Source Type: research
Publication date: Available online 29 November 2019Source: Journal of Molecular StructureAuthor(s): B.N. Ravi, Keshavayya J, Mallikarjuna N. M, Vinod Kumar, Shivanand KandgalAbstractAzo molecules (A1-A3) were prepared by reacting 2-aminothiazole with three different pyridone derivatives as coupling components, viz., 6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile, 6-hydroxy-1,4-dimethyl-2-oxo-1,2-dihydropyridine-3-nitrile and 1-ethyl-6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile via diazo-coupling reactions, under appropriate experimental conditions. The structural characteristics of the synthesiz...
Source: Journal of Molecular Structure - Category: Molecular Biology Source Type: research
Condition:   Pulmonary Tuberculosis Interventions:   Drug: Moxifloxacin, Isoniazid, Rifampicin;   Drug: Rifampicin,Isoniazid,Pyrazinamide,Ethambutol Sponsor:   Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Tuberculosis Intervention:   Other: INSTEP2 intervention package Sponsors:   Universitas Padjadjaran;   University of Otago;   Harvard University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Latent Tuberculosis Intervention:   Other: TB Infection ECHO Sponsors:   Kent Hospital, Rhode Island;   National Institute of General Medical Sciences (NIGMS) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Pulmonary Tuberculosis Interventions:   Drug: Moxifloxacin, Isoniazid, Rifampicin;   Drug: Rifampicin,Isoniazid,Pyrazinamide,Ethambutol Sponsor:   Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Tuberculosis Intervention:   Other: INSTEP2 intervention package Sponsors:   Universitas Padjadjaran;   University of Otago;   Harvard University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Latent Tuberculosis Intervention:   Other: TB Infection ECHO Sponsors:   Kent Hospital, Rhode Island;   National Institute of General Medical Sciences (NIGMS) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Source: BMJ News - Category: General Medicine Source Type: research
By SAURABH JHA, MD Slumdog TB No one knows who gave Rahul Roy tuberculosis. Roy’s charmed life as a successful trader involved traveling in his Mercedes C class between his apartment on the plush Nepean Sea Road in South Mumbai and offices in Bombay Stock Exchange. He cared little for Mumbai’s weather. He seldom rolled down his car windows – his ambient atmosphere, optimized for his comfort, rarely changed. Historically TB, or “consumption” as it was known, was a Bohemian malady; the chronic suffering produced a rhapsody which produced fine art. TB was fashionable in Victorian Britain...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Artificial Intelligence Health Tech Saurabh Jha TB tuberculosis Source Type: blogs
More News: Nutrition | Research | Tuberculosis